Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2/3 1

Status

Withdrawn 1Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 6Lymphoid 5Tumor-Agnostic 4Breast 4Head & Neck 3Thoracic 2Plasma cell 2Other 2Genitourinary 2Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Endocrine 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Glutamine × Tumor-Agnostic × Clear all
NCT07287592 2025-12-17

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Ain Shams University

Phase 3 Not yet recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

NCT04710290 2021-01-25

A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

E-DA Hospital

Phase 2/3 Unknown
90 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01032512 2018-02-19

Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical Oncology

University of Chile

Phase 3 Withdrawn
Tumor-Agnostic

Neoplasms

NCT00003170 2016-07-14

Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
129 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡